PROCEPT BioRobotics Corporation is a commercial-stage surgical robotics company. The Company is focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AQUABEAM Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia (BPH). The Company's proprietary AQUABEAM Robotic System delivers Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. Aquablation therapy delivers effective, safe and durable outcomes for males suffering from lower urinary tract symptoms (LUTS), due to BPH, which are independent of prostate size and shape or surgeon experience.
Company Information
About this company
Key people
Larry L. Wood
President, Chief Executive Officer, Director
Kevin Waters
Executive Vice President, Chief Financial Officer
Alaleh Azarkhish Nouri
Executive Vice President, Chief Legal Officer, Corporate Secretary
Hisham Shiblaq
Executive Vice President, Chief Commercial Officer
Thomas M. Prescott
Independent Chairman of the Board
Antal Desai
Independent Director
Amy M. Dodrill
Independent Director
Mary Garrett
Independent Director
Taylor C. Harris
Independent Director
Click to see more
Key facts
- Shares in issue55.88m
- EPICPRCT
- ISINUS74276L1052
- LocationUnited States
- SectorHealthcare
- IndustryMedical Equipment & Supplies
- Market cap$1.62bn
- Employees756
- ExchangeNASDAQ
- IndexTR Equity United States Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.